© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Why is Early Treatment of Atopic Dermatitis So Important? Mona Shahriari, MD, Says it Could Change a Life
June 26th 2025
Revolutionizing Atopic Dermatitis (RAD)
Atopic dermatitis is not just "another rash on the schedule. It could the the reason that patient doesn't leave the house."
Jiade Yu, MD, on the Power of Multidisciplinary Collaboration in Atopic Dermatitis
June 25th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Multidisciplinary collaboration at disease-specific meetings drives clinical and therapeutic progress in AD, Dr Yu told Patient Care.
A Visible Disease with Invisible Pain: Mona Shahriari Discusses Suicide Risk in Atopic Dermatitis
June 25th 2025
Revolutionizing Atopic Dermatitis (RAD)
Dermatologists aren't trained in mental health but once in practice they need to have a deep appreciation for the emotional impact of diseases like AD and a low bar for mental health referral.
Jiade Yu, MD, on the Future of Chronic Hand Eczema Treatment
June 24th 2025
Revolutionizing Atopic Dermatitis (RAD)
At RAD 2025, Dr Yu shared hopes for more real-world data and targeted treatment approaches for chronic hand eczema.
Early Atopic Dermatitis Can Be Mild, But the Threshold for Dermatology Referral Should be Low: Mona Shahriari, MD
June 24th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Yale dermatologist Mona Shahriari, MD, urged primary care clinicians to refer patients with AD who don't improve to prevent cumulative emotional burden.
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions
June 20th 2025
The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.
Atopic Dermatitis in Focus: 3 Expert Pearls for Primary Care
June 19th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Expert insights on the psychosocial burden of AD, flexible dosing, and cross-specialty collaboration in pediatric care.
Johann Gudjonsson, MD, PhD, on Emerging AD Therapies: From Single Targets to Combination Approaches
June 19th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Johann Gudjonsson, MD, PhD, on investigational AD treatments, including anti–IL-31 receptor antibodies, anti–IL-13 treatments, IL-4 receptor blockers, JAK inhibitors, and new topical agents.
When the Diagnosis is Topical Steroid Withdrawal Syndrome, a Compassionate, Collaborative History is Essential
June 19th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Brad Glick, DO, MPH, discusses the intensity of TSW symptoms and cautions against assuming there is mental health disturbance at work.
Johann Gudjonsson, MD, PhD: Role of OX-40 Pathway in Atopic Dermatitis Pathogenesis
June 18th 2025
Revolutionizing Atopic Dermatitis (RAD)
Johann Gudjonsson, MD, discusses how OX-40/OX-40L signaling drives immune activation in AD and its emerging role as a genetic and therapeutic target.